Common Types of Thyroid Disease in Postpartum Women with Hypothyroidism
Postpartum thyroiditis (PPT) is the most common thyroid disorder in postpartum women with hypothyroidism, affecting 5-10% of women within the first year after delivery, with Hashimoto's thyroiditis being the most frequent underlying cause in industrialized nations. 1
Postpartum Thyroiditis (PPT)
Prevalence and Risk Factors
- Affects 5-10% of women in the first postpartum year 1
- Higher prevalence (up to 25%) in women with:
- 70% risk of recurrence in subsequent pregnancies 1, 3
Clinical Patterns
PPT typically follows one of these patterns:
- Classic biphasic pattern (22% of cases): Transient hyperthyroidism followed by transient hypothyroidism 4
- Isolated hypothyroidism (48% of cases): Most common presentation 4
- Isolated thyrotoxicosis (30% of cases): Hyperthyroid phase only 4
Underlying Causes in Postpartum Women with Hypothyroidism
Hashimoto's thyroiditis (chronic autoimmune thyroiditis): Most common cause in industrialized nations 5
Other causes of hypothyroidism in postpartum women 5:
- Subacute thyroiditis
- History of radioactive iodine therapy
- Previous thyroidectomy
- Iodine deficiency (most common cause worldwide)
Clinical Presentation and Diagnosis
Hyperthyroid Phase (Typically 1-4 months postpartum) 7
- Palpitations, heat intolerance, anxiety, weight loss 1
- Differentiate from postpartum Graves' disease:
Hypothyroid Phase (Typically peaks around 19 weeks postpartum) 3
- Fatigue (most common symptom) 3, 4
- Cold intolerance, dry skin, impaired memory, aches and pains 3, 4
- Weight gain, intellectual slowness, constipation 5
Laboratory Testing
- TSH, Free T4 (FT4) or Free T4 Index (FTI) 1
- Anti-thyroid peroxidase (anti-TPO) antibodies to confirm autoimmune etiology 1
- Consider Free T3 if clinical suspicion is high but TSH and FT4 are incongruent 1
Long-term Outcomes
- Approximately 25-30% of women with PPT develop permanent hypothyroidism within 3 years 3
- Long-term studies show up to 50% develop permanent hypothyroidism within 7-9 years 3
- Risk factors for permanent hypothyroidism:
Management Considerations
Hyperthyroid Phase
- Beta-blockers (e.g., propranolol) for symptomatic relief 1
- Antithyroid medications (propylthiouracil, methimazole) are NOT indicated as PPT is destructive thyroiditis rather than increased hormone production 1
Hypothyroid Phase
- Levothyroxine therapy recommended for:
- Symptomatic patients with TSH 4-10 mU/L
- All patients with TSH >10 mU/L
- Starting dose: approximately 1.6 mcg/kg/day 1